Can talk therapy mend more than mood in marital crisis?
NCT ID NCT07808021
First seen Sep 08, 2026 · Last updated Sep 09, 2026 · Updated 1 time
Summary
This trial tests whether two types of talk therapy, Acceptance and Commitment Therapy (ACT) and Cognitive Behavioral Therapy (CBT), can ease depression and related issues better than usual care in people who have major depression and are facing marital crisis. About 120 adults will be randomly assigned to one of three groups: ACT, CBT, or usual care. Each therapy runs for eight weekly group sessions. Researchers will measure depressive symptoms, anxiety, marital satisfaction, intimacy, quality of life, and emotional avoidance before, right after, and at 12 and 24 weeks after the therapy ends.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Acceptance and Commitment Therapy (ACT) and Cognitive Behavioral Therapy (CBT), each combined with a single antidepressant
- What this could lead to
- If ACT or CBT proves more effective than usual care, it could offer a structured, time-limited therapy option for people with depression and relationship distress.
- What could go wrong
- The trial is relatively small and early, and results may not apply to all populations. Talk therapies require active participation, and benefits may fade after sessions end.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 120 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jan 2027
An estimate. Start dates often move.
- Expected to finish
-
Apr 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
20 to 60 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Meets DSM-5-TR diagnostic criteria for major depressive disorder, confirmed by the Mini International Neuropsychiatric Interview (MINI) structured clinical interview (American Psychiatric Association, 2022). 2. Beck Depression Inventory-II (BDI-II) total score of 20 or above, indicating moderate to severe depressive symptoms (Beck et al., 1996). 3. Dyadic Adjustment Scale (DAS) total score of 97 or below, operationally defining marital crisis (Spanier, 1976). 4. Age between 20 and 60 years. 5. Currently taking a single antidepressant medication for a minimum of two weeks. Rather than being required to remain on an unchanged dose, participants agree to have their antidepressant regimen managed by their treating psychiatrist according to clinical need for the duration of the study; any change in medication or dose is documented and included as a time-varying covariate in the analysis. Exclusion Criteria: 1. Current diagnosis of symptomatic bipolar mood disorder or psychotic disorder which would interfere with their ability to answer questionnaires and participate in the study. 2. History of substance abuse or acute alcohol use disorder. 3. Prior receipt of any structured psychotherapy before study enrollment. 4. Severe physical illness or cognitive impairment that would prevent meaningful participation in group therapy sessions or completion of assessment instruments. 5. Current exposure to active intimate partner violence or domestic abuse. This is screened at the face-to-face assessment using a brief standardized instrument, and it is applied to safeguard participant safety during the disclosure of marital distress in the group setting. Individuals who screen positive are not enrolled and are referred to appropriate local domestic-violence support services.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Anxiety are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Yunfu City Yuncheng District People's Hospital
Yunfu, Guangdong, 526060, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Biotype-assigned augmentation approach in resistant Late-Life depression (BAARD): a randomized controlled trial
- Haptic feedback for improved interoceptive awareness and mental well-being: a comprehensive In-the-Wild study for wellness
- The effect of stress ball use during femoral arterial sheath removal after coronary angiography on pain, anxiety, patient satisfaction, and hemodynamic parameters
- The dynamic mechanism of mindfulness intervention for emotional distress (MIED) based on ecological moment measurement
- Intramuscular ketamine for suicidal patients in the evanston hospital emergency department for suicidal distress: a pilot study
- Project QUIT+: adapting and testing a smoking cessation intervention for transgender and gender expansive individuals